Memorial Sloan Kettering Cancer Center

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Myeloma
Leukemia
Lymphoma
Hematologic Transplantation and Malignancies
Breast
Lung
Gastrointestinal
Genitourinary
Gynecologic
Skin
Head and Neck
Brain
General Oncology
Palliative Care
MPN
COVID-19
Events

Playback speed

10 seconds

Frontline Management of Advanced GEJ Cancers: Will 5FU/Oxaliplatin + Nivo Become the New SoC? Does Adjuvant Nivo Show DFS Benefit?

By Memorial Sloan Kettering Cancer Center FEATURING Yelena Y. Janjigian

414 views

March 4, 2021

Comments 0

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri

Gastrointestinal

Organ Preservation in Rectal Cancer: Neoadjuvant Short-Course RT vs.…

Memorial Sloan Kettering Cancer Center

P. Romesser

76 views

ESMO 2024 Insights: DESTINY-Gastric03 - T-DXd Monotherapy and Combin…

2024 ESMO Annual Meeting Insights Hub

Y. Janjigian

125 views

ASCO® GI 2024 Insights: "PROOF 301 Trial - Oral FGFR Inhibitor Infig…

Insights from 2024 ASCO® GI Annual Meeting

G. Abou-Alfa

172 views

CheckMate 649 Trial Biomarker Analyses of Nivo + Ipi vs. Chemo for P…

ecancer

Y. Y. Janjigian

231 views

Updates in Rectal Cancer: Optimizing Response, Preserving the Organ,…

Total Health

J. Smith

1.2K views

Pathophysiologic Foundations in HCC/BTC: Immune System as a Therapeu…

CE Concepts

J. Harding

78 views

ASCO GI 2023 3-Year Follow-Up From CheckMate 649: Nivo + Chemo vs. C…

ASCO GI 2023 Conference Coverage

Y. Y. Janjigian

598 views

ASCO GI 2023 ctDNA for Response Assessment in Patients With Anal Can…

ASCO GI 2023 Conference Coverage

J. Alvarez

130 views

ASCO GI 2023 on Organ Preservation and Total Neoadjuvant Therapy for…

ASCO GI 2023 Conference Coverage

P. Romesser

360 views

Advances in IO and Targeted Agents in Gastroesophageal Cancer

Debbie's Dream Foundation

D. Ilson

616 views

An Overview of Treatment Advances in Gastric Cancer

ecancer

D. Ilson

327 views

ASCO 2022: Single-Agent PD-1 Blockade as Curative-Intent Treatment i…

ecancer

A. Cercek

64 views

ASCO 2022 Targeting HER2 Mutation-Positive Advanced Biliary Tract Ca…

ASCO 2022 Conference Coverage

J. Harding

91 views

Lecture Summary - ASCO 2022 Targeting HER2 Mutation-Positive Advance…

ASCO 2022 Conference Coverage

J. Harding

16 views

ASCO 2022 on PROOF 301 Trial: Updates on Infigratinib vs. Gemcitabin…

ASCO 2022 Conference Coverage

G. Abou-Alfa

1.1K views

Lecture Summary - ASCO 2022 Updates on Infigratinib vs. Gemcitabine …

ASCO 2022 Conference Coverage

G. Abou-Alfa

104 views

Tremelimumab and Durvalumab as 1L in Unresectable HCC: Phase 3 HIMAL…

ecancer

G. Abou-Alfa

257 views

Incidental Findings From Somatic Testing and Implications for Heredi…

Collaborative Group of the Americas for Inherited Gastrointestinal Cancers

Z. Stadler

145 views

ASCO GI 2022 on a Quality-Adjusted Time Without Symptoms or Toxicity…

ASCO GI 2022 Conference Coverage

R. Sugarman

433 views

ASCO GI 2022 Updates on the Dose-Escalation & Dose-Expansion Study o…

ASCO GI 2022 Conference Coverage

Y. Y. Janjigian

230 views

ESMO 2021 Update on Nivo + Chemo or Ipi vs. Chemo as 1L Treatment in…

Memorial Sloan Kettering Cancer Center

Y. Y. Janjigian

212 views

ESMO 2021 Abstract Review on Genomic Landscape of Late-Stage Gastric…

Memorial Sloan Kettering Cancer Center

Y. Y. Janjigian

204 views

Gastric Cancer: Advances in Systemic Therapy

Debbie's Dream Foundation

D. Ilson

117 views

2021 ASCO CRC Updates: 1L Pembro vs. Chemo, Maintenance Chemo, 2L an…

2021 ASCO Virtual Direct™ Highlights

L. Connell

64 views

1L Treatment Updates for Advanced GE/GEJ Cancers: OS Data for Nivo+I…

Memorial Sloan Kettering Cancer Center

Y. Janjigian

36 views

Frontline Management of Advanced GEJ Cancers: Will 5FU/Oxaliplatin +…

Memorial Sloan Kettering Cancer Center

Y. Y. Janjigian

414 views

BRAF Alterations in Advanced CRC: How Common Are V600E Mutations? Ho…

Memorial Sloan Kettering Cancer Center

R. Yaeger

175 views

Liver-Directed Therapy for mCRC: What Is the Goal, When to Use and H…

Memorial Sloan Kettering Cancer Center

A. Cercek

207 views

2020 ESMO Update on mPDAC: Does the Addition of Dual Immune Checkpoi…

2020 Virtual ESMO Review

L. Connell

229 views

2020 ESMO Update on Metastatic Pancreatic Cancer: What Does the Qoli…

2020 Virtual ESMO Review

L. Connell

64 views

2020 ASCO Update on Locoregional CRC: 3 vs. 6 Months of Adjuvant Oxa…

2020 ASCO Virtual Direct™ Highlights

L. Connell

395 views

2020 ASCO Update on Advanced CRC: Should Pembrolizumab Be The New So…

2020 ASCO Virtual Direct™ Highlights

L. Connell

499 views

2020 ASCO Update on Advanced CRC: Is Recently FDA Approved Encorafen…

2020 ASCO Virtual Direct™ Highlights

L. Connell

190 views

The Role of Modern RT Techniques in Management of Esophagogastric Ca…

Memorial Sloan Kettering Cancer Center

A. Wu

100 views

Advanced Surgical Techniques for Early Stage Esophagogastric Cancer:…

Memorial Sloan Kettering Cancer Center

D. Molena

32 views

Current and Future Personalized Systemic Targets in Esophagogastric …

Memorial Sloan Kettering Cancer Center

G. Ku

288 views